BBP Among Health Care ETFs
End-of-day Nov 18, 2026 · 39 Health care ETFs by Max
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.7% | −6.6% | −7.4% | −8.2% | +22.6% | +26.5% | +107.0% | +92.6% | +222.9% | +281.9% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$57 of every $1,000 in BBP is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 5.66% | $565.91 | 35K | $7.3M |
| 2 | XERSXeris Biopharma | Healthcare | 3.38% | $337.93 | 258K | $4.3M |
| 3 | IOVAIovance Biotherapeutics | Healthcare | 2.52% | $252.07 | 430K | $3.2M |
| 4 | KNSAKiniksa Pharmaceuticals International | Healthcare | 2.50% | $250.35 | 34K | $3.2M |
| 5 | VSTMVerastem | Healthcare | 2.47% | $246.84 | 428K | $3.2M |
| 6 | ADMAADMA Biologics | Healthcare | 2.27% | $226.75 | 214K | $2.9M |
| 7 | OMEROmeros | Healthcare | 2.18% | $217.65 | 201K | $2.8M |
| 8 | REGNRegeneron Pharmaceuticals | Healthcare | 2.14% | $213.63 | 2,863 | $2.7M |
| 9 | BGNEBeOne Medicines | — | 2.13% | $213.40 | 6,628 | $2.7M |
| 10 | HALOHalozyme Therapeutics | Healthcare | 1.89% | $188.60 | 25K | $2.4M |
| 11 | ZLABZai Lab | Healthcare | 1.88% | $188.27 | 103K | $2.4M |
| 12 | GILDGilead Sciences | Healthcare | 1.85% | $185.15 | 14K | $2.4M |
| 13 | IRWDIronwood Pharmaceuticals | — | 1.82% | $182.23 | 480K | $2.3M |
| 14 | RYTMRhythm Pharmaceuticals | Healthcare | 1.80% | $180.21 | 20K | $2.3M |
| 15 | RIGLRigel Pharmaceuticals | Healthcare | 1.78% | $178.45 | 53K | $2.3M |
of the $111B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 5.66% |
| 2 | XERS | Xeris Biopharma | 3.38% |
| 3 | IOVA | Iovance Biotherapeutics | 2.52% |
| 4 | KNSA | Kiniksa Pharmaceuticals International | 2.50% |
| 5 | VSTM | Verastem | 2.47% |
| 6 | ADMA | ADMA Biologics | 2.27% |
| 7 | OMER | Omeros | 2.18% |
| 8 | REGN | Regeneron Pharmaceuticals | 2.14% |
| 9 | BGNE | BeOne Medicines | 2.13% |
| 10 | HALO | Halozyme Therapeutics | 1.89% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 20, 2017 | Dec 27, 2017 | $0.0723 |
| Dec 21, 2015 | Dec 29, 2015 | $0.40 |